期刊文献+

熊果酸对干扰素γ刺激HaCaT细胞产生白细胞介素33的影响 被引量:2

Effects of ursolic acid on interleukin-33 expression in HaCaT cells induced by interferon-γ
原文传递
导出
摘要 目的:探讨熊果酸对干扰素γ(IFN?γ)刺激HaCaT细胞产生白细胞介素33(IL?33)的影响及其机制。方法不同浓度熊果酸(0、0.1、1、5、10、20、40、80μmol/L)分别刺激HaCaT细胞24、48、72 h,MTT法检测其对细胞增殖的影响。将HaCaT细胞与200μg/L IFN?γ共培养建成炎性细胞模型,再与10和15μmol/L熊果酸共培养,以IFN?γ诱导的HaCaT炎性细胞模型为对照,探讨熊果酸的抗炎作用,RT?PCR法检测IL?6和IL?33 mRNA的表达,Western印迹法检测IL?33、p?ERK1/2和ERK1/2蛋白的表达。结果 MTT法检测显示,5~20μmol/L熊果酸作用24 h对细胞活力影响不大,而40~80μmol/L熊果酸在各个时间点均可明显抑制HaCaT细胞增殖(P〈0.05),故后续实验采用10和15μmol/L浓度。HaCaT细胞经IFN?γ刺激后,IL?33 mRNA(0.812±0.036)、IL?6 mRNA(0.947±0.091)表达量和IL?33蛋白表达(1.317±0.119)均显著高于空白对照组(分别为0.412±0.021、0.595±0.030和0.147±0.036,均P〈0.05);而IFN?γ+10μmol/L熊果酸组(分别为0.447±0.042、0.437±0.099和0.923±0.058)和IFN?γ+15μmol/L熊果酸组(分别为0.438±0.028、0.350±0.075和0.564±0.113)又较IFN?γ组(分别为0.812±0.036、0.947±0.091和1.317±0.119)显著降低(均P〈0.05),且这两个熊果酸组IL?33 mRNA水平与空白对照组相比差异无统计学意义(P〉0.05),而IFN?γ+15μmol/L熊果酸组IL?33蛋白水平显著低于IFN?γ+10μmol/L熊果酸组(P〈0.05)。HaCaT细胞分别经IFN?γ刺激5、60 min后,p?ERK1/2蛋白表达均明显高于空白对照组。IFN?γ+15μmol/L熊果酸5 min组和60 min组p?ERK1/2蛋白的相对表达量(0.458±0.053、0.302±0.054)分别低于IFN?γ5 min组(0.941±0.042)和60 min组(0.509±0.032),差异均有统计学意义(P〈0.05),而总ERK1/2蛋白表达量不变。结论熊果酸能够降低IFN?γ刺激的HaCaT细胞IL?33的表达量,其机制可能与调节ERK信号通路相关蛋白的表达有关。 Objective To evaluate effects of ursolic acid (UA) on interleukin?33 (IL?33) expression in HaCaT cells induced by interferon?γ(IFN?γ), and to explore their mechanism. Methods Some HaCaT cells were treated with UA at different concentrations(0, 0.1, 1, 5, 10, 20, 40 and 80μmol/L)for 24, 48 and 72 hours separately. Then, methyl thiazolyl tetrazolium(MTT)assay was conducted to evaluate cell proliferative activity. A cell model of inflammation was established by culture of HaCaT cells with the presence of 200μg/L IFN?γ. Some HaCaT cells were classified into several groups to be treated with IFN?γ(200μg/L)and UA(10 and 15μmol/L)alone or in combination (firstly treated with IFN?γ followed by UA treatment), and those receiving no treatment served as the blank control group. Reverse transcription PCR (RT?PCR) was performed to detect mRNA expressions of IL?6 and IL?33, and Western?blot analysis to measure IL?33 protein expression after 12?hour culture. The expressions of extracelluar signal?regulated kinase 1/2(ERK1/2)and phosphorylated ERK1/2(p?ERK1/2)were also measured by Western?blot analysis after 5?and 60?minute treatments with IFN?γand UA alone or in combination. Results MTT assay showed that the treatments with 5-20μmol/L UA for 24 hours had no effects on cell proliferative activity, while 40-80μmol/L UA could significantly inhibit it at 24, 48 and 72 hours (all P 〈 0.05). Thus, 10 and 15 μmol/L were chosen as the concentrations of UA for further study. After the treatment with 200μg/L IFN?γ, there was a significant increase in the expressions of IL?33 mRNA(0.812 ± 0.036 vs. 0.412 ± 0.021), IL?6 mRNA(0.947 ± 0.091 vs. 0.595 ± 0.030)and IL?33 protein(1.317 ± 0.119 vs. 0.147 ± 0.036)in HaCaT cells compared with the blank control group(all P〈0.05). Compared with the IFN?γgroup, the IFN?γ+10?μmol/L UA group and IFN?γ+15?μmol/L UA group both showed significantly decreased expressions of IL?33 mRNA(0.447 ± 0.042 and 0.438 ± 0.028 respectively, both P〈0.05), IL?6 mRNA(0.437 ± 0.099 and 0.350 ± 0.075 respectively, both P〈0.05)and IL?33 protein(0.923 ± 0.058 and 0.564 ± 0.113 respectively, both P〈0.05). There were no significant differences in IL?33 mRNA expression between the IFN?γ+10?or 15?μmol/L UA group and blank control group(P〉0.05), while IL?33 protein expression was significantly lower in the IFN?γ+15?μmol/L UA group than in the IFN?γ+10?μmol/L UA group(P〈0.05). The p?ERK1/2 protein expression significantly increased in HaCaT cells treated with IFN?γ for 5 and 60 minutes compared with the blank control group, but significantly decreased in the IFN?γ+15?μmol/L UA group compared with the IFN?γgroup(0.458 ± 0.053 vs. 0.941 ± 0.042 at 5 minutes, 0.302 ± 0.054 vs. 0.509 ± 0.032 at 60 minutes, both P 〈 0.05). However, no significant differences were observed in the total ERK1/2 protein expression between the IFN?γ+15?μmol/L UA group and IFN?γgroup at 5 or 60 minutes. Conclusion UA can suppress IL?33 expression in HaCaT cells induced by IFN?γ, likely by regulating expressions of the ERK signaling pathway?related proteins.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2016年第7期495-500,共6页 Chinese Journal of Dermatology
基金 基金项目:河南省教育厅科学技术研究重点项目(13A320852) 河南省中青年卫生科技创新型人才工程专项基金(201004159) 河南省医学科技攻关计划重点项目(201502016)
关键词 熊果酸 干扰素Γ 白细胞介素1 白细胞介素6 细胞外信号调节MAP激酶类 HACAT细胞 细胞介素33 Ursolic acid Interferon-gamma Interleukin- 1 Interleukin-6 Extracellular signal-regulated MAPkinases HaCaT cells Interleukin-33
  • 相关文献

参考文献22

  • 1Krueger GG, Langley RG, Leonardi C, et al. A human interleukin- 12/23 monoclonal antibody for the treatment of psoriasis [J]. N Engl J Med, 2007, 356(6): 580-592. DOI: 10.1056/NEJMoa062382.
  • 2Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis [J]. Nature, 2007, 445 (7130): 866-873. DOI: 10. 1038/nature05663.
  • 3Ratner M. IL-17-targeting biologics aim to become standard of care in psoriasis [J]. Nat Biotechnol, 2015, 33 (1): 3-4. DOI: 10.1038/nbtO115-3.
  • 4Sehmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1- like eytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines [J ]. Immunity, 2005, 23(5 ): 479-490. DOI: 10.1016/j.immuni.2005.09.015.
  • 5Hueber AJ, Alves-Filho JC, Asquith DL, et al. IL-33 induces skin inflammation with mast cell and neutrophil activation [J]. Eur J Immunol, 2011, 41 (8): 2229-2237. DOI: 10.1002/eji. 201041360.
  • 6Liu J. Pharmacology of oleanolic acid and ursolie acid [ J ]. J Ethnopharmacol, 1995, 49 (2): 57-68.
  • 7Liobikas J, Majiene D, Trumbeckaite S, et al. Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria [J]. J Nat Prod, 2011,74(7): 1640-1644. DOI: 10.1021/np200060p.
  • 8Checker R, Sandur SK, Sharma D, et al. Potent anti-inflammatory activity of ursolie acid, a triterpenoid antioxidant, is mediated through suppression of NF-KB, AP-1 and NF-AT [J]. PLoS One, 2012, 7(2): e31318. DOI: 10.1371/journal.pone.0031318.
  • 9Shanmugam MK, Dai X, Kumar AP, et al. Ursolic acid in cancer prevention and treatment: molecular targets, pharmaeokineties and clinical studies [J]. Biochem Pharmaeol, 2013, 85 (11 ): 1579- 1587. DOI: 10.1016/j.bcp.2013.03.006.
  • 10Ikeda Y, Murakami A, Fnjimura Y, et al. Aggregated ursolic acid, a natural triterpenoid, induces IL- lbeta release from murine peritoneal macrophages: role of CD36 [J]. J Immunol, 2007, 178 (8): 4854-4864.

二级参考文献33

  • 1Miller AM. Role of IL-33 in inflammation and disease[J]. J Inflamm (Lond), 2011,8(1) : 22 -36.
  • 2Onda H, Kasuya H, Takakura K, et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemor-rhage [ J ]. J Cereb Blood Flow Metab, 1999, 19(11) : 1279 -1288.
  • 3Baekkevold ES, Roussign6 M, Yamanaka T, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules[ J]. Am J Pathol, 2003, 163 ( 1 ) : 69 - 79.
  • 4Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1- like cytokine that signals v/a the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines [ J ]. Immunity, 2005, 23 (5) : 479 - 490.
  • 5Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells [ J]. Trends Immunol, 2012, 33 ( 8 ) : 389 - 396.
  • 6Tominaga S. A putative protein of a growth specific eDNA from BALB/c 313 cells is highly similar to the extracellular portion of mouse interleukin I receptor [ J]. FEBS Lett, 1989, 258 (2) : 301 - 304.
  • 7Liew FY, Pitman NI, Mclnnes lB. Disease-associated function of ID33: the new kid in the IL-1 family[J]. Nat Rev Immunol, 2010, 10(2) : 103 -111.
  • 8Miller AM, Liew FY. The IL-33/ST2 pathway-A new therapeutic target in cardiovascular disease [ J]. Pharmacol Ther, 2011, 131(2) : 179 -186.
  • 9Nakae S, Morita H, Ohno T, et al. Role of interleukin-33 in innate-type immune cells in allergy [ J ]. Allergol hat, 2013, 62 (1) : 13 -20.
  • 10Yu SL, Wong CK, Tam KS. The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus[J]. Expert Rev Clin Immunol, 2013, 9 ( 8 ) : 739 - 749.

共引文献19

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部